title: Dydrogesterone-induced hepatitis and autoimmune hemolytic anemia.
abstract: Dydrogesterone, similar to women's natural progesterone, has been used in a wide range of gynecological conditions. Despite its widespread use, dydrogesterone-induced hepatotoxicity and dydrogesterone-induced hemolytic anemia have, to the best of our knowledge, never been reported previously. We describe a case of hepatitis and warm antibody hemolytic anemia due to dydrogesterone.
authors.affiliation: Division of Gastroenterology, School of Medicine, Mersin University, Mersin, Turkey. enginaltintas@mersin.edu.tr
authors.forename: Engin
authors.initials: E
authors.lastname: Altintaş
authors.forename: Dilek
authors.initials: D
authors.lastname: Oğuz
authors.forename: Sabite
authors.initials: S
authors.lastname: Kaçar
authors.forename: Yasemin
authors.initials: Y
authors.lastname: Ozderin
authors.forename: Orhan
authors.initials: O
authors.lastname: Sezgin
authors.forename: Neslihan Inci
authors.initials: NI
authors.lastname: Zengin
mesh_terms: D000208:Acute Disease; D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced* / Q000628:therapy; D001707:Biopsy, Needle; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000628:therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004394:Dydrogesterone / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008111:Liver Function Tests; D018570:Risk Assessment; D012720:Severity of Illness Index
chemical_list: D004394:Dydrogesterone